360 related articles for article (PubMed ID: 14613856)
21. Protein kinase G phosphorylates Cav1.2 alpha1c and beta2 subunits.
Yang L; Liu G; Zakharov SI; Bellinger AM; Mongillo M; Marx SO
Circ Res; 2007 Aug; 101(5):465-74. PubMed ID: 17626895
[TBL] [Abstract][Full Text] [Related]
22. Modulation of Ca2+ sensitivity by cyclic nucleotides in smooth muscle from protein kinase G-deficient mice.
Bonnevier J; Fässler R; Somlyo AP; Somlyo AV; Arner A
J Biol Chem; 2004 Feb; 279(7):5146-51. PubMed ID: 14610087
[TBL] [Abstract][Full Text] [Related]
23. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
MacDonell KL; Diamond J
Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
[TBL] [Abstract][Full Text] [Related]
24. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
[TBL] [Abstract][Full Text] [Related]
25. Modulation of Ca2+ channels by cyclic nucleotide cross activation of opposing protein kinases in rabbit portal vein.
Ruiz-Velasco V; Zhong J; Hume JR; Keef KD
Circ Res; 1998 Mar; 82(5):557-65. PubMed ID: 9529160
[TBL] [Abstract][Full Text] [Related]
26. Carvedilol induces biased β1 adrenergic receptor-nitric oxide synthase 3-cyclic guanylyl monophosphate signalling to promote cardiac contractility.
Wang Q; Wang Y; West TM; Liu Y; Reddy GR; Barbagallo F; Xu B; Shi Q; Deng B; Wei W; Xiang YK
Cardiovasc Res; 2021 Aug; 117(10):2237-2251. PubMed ID: 32956449
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide-cGMP-protein kinase G pathway negatively regulates vascular transient receptor potential channel TRPC6.
Takahashi S; Lin H; Geshi N; Mori Y; Kawarabayashi Y; Takami N; Mori MX; Honda A; Inoue R
J Physiol; 2008 Sep; 586(17):4209-23. PubMed ID: 18617565
[TBL] [Abstract][Full Text] [Related]
28. NO donors potentiate the beta-adrenergic stimulation of I(Ca,L) and the muscarinic activation of I(K,ACh) in rat cardiac myocytes.
Abi-Gerges N; Szabo G; Otero AS; Fischmeister R; Méry PF
J Physiol; 2002 Apr; 540(Pt 2):411-24. PubMed ID: 11956332
[TBL] [Abstract][Full Text] [Related]
29. Nitric Oxide Protects L-Type Calcium Channel of Cardiomyocyte during Long-Term Isoproterenol Stimulation in Tail-Suspended Rats.
Yue ZJ; Xu PT; Jiao B; Chang H; Song Z; Xie MJ; Yu ZB
Biomed Res Int; 2015; 2015():780814. PubMed ID: 26167497
[TBL] [Abstract][Full Text] [Related]
30. Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes.
Vandecasteele G; Verde I; Rücker-Martin C; Donzeau-Gouge P; Fischmeister R
J Physiol; 2001 Jun; 533(Pt 2):329-40. PubMed ID: 11389195
[TBL] [Abstract][Full Text] [Related]
31. Role of cGMP-inhibited phosphodiesterase and sarcoplasmic calcium in mediating the increase in basal heart rate with nitric oxide donors.
Musialek P; Rigg L; Terrar DA; Paterson DJ; Casadei B
J Mol Cell Cardiol; 2000 Oct; 32(10):1831-40. PubMed ID: 11013127
[TBL] [Abstract][Full Text] [Related]
32. Cholinergic modulation of the basal L-type calcium current in ferret right ventricular myocytes.
Bett GC; Dai S; Campbell DL
J Physiol; 2002 Jul; 542(Pt 1):107-17. PubMed ID: 12096055
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP-elevated L-type calcium current in guinea-pig ventricular myocytes.
Ziolo MT; Lewandowski SJ; Smith JM; Romano FD; Wahler GM
Br J Pharmacol; 2003 Mar; 138(5):986-94. PubMed ID: 12642401
[TBL] [Abstract][Full Text] [Related]
34. Regulation of L-type Ca
Sandoval A; Duran P; Gandini MA; Andrade A; Almanza A; Kaja S; Felix R
Cell Calcium; 2017 Sep; 66():1-9. PubMed ID: 28807144
[TBL] [Abstract][Full Text] [Related]
35. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
36. Activation of the mitogen activated protein kinase extracellular signal-regulated kinase 1 and 2 by the nitric oxide-cGMP-cGMP-dependent protein kinase axis regulates the expression of matrix metalloproteinase 13 in vascular endothelial cells.
Zaragoza C; Soria E; López E; Browning D; Balbín M; López-Otín C; Lamas S
Mol Pharmacol; 2002 Oct; 62(4):927-35. PubMed ID: 12237340
[TBL] [Abstract][Full Text] [Related]
37. Chronic receptor-mediated activation of Gi/o proteins alters basal t-tubular and sarcolemmal L-type Ca²⁺ channel activity through phosphatases in heart failure.
Kashihara T; Nakada T; Shimojo H; Horiuchi-Hirose M; Gomi S; Shibazaki T; Sheng X; Hirose M; Hongo M; Yamada M
Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1645-54. PubMed ID: 22307674
[TBL] [Abstract][Full Text] [Related]
38. Role of phospholamban in cyclic GMP mediated signaling in cardiac myocytes.
Zhang Q; Scholz PM; Pilzak A; Su J; Weiss HR
Cell Physiol Biochem; 2007; 20(1-4):157-66. PubMed ID: 17595525
[TBL] [Abstract][Full Text] [Related]
39. Nitric Oxide-cGMP-PKG Pathway Acts on Orai1 to Inhibit the Hypertrophy of Human Embryonic Stem Cell-Derived Cardiomyocytes.
Wang Y; Li ZC; Zhang P; Poon E; Kong CW; Boheler KR; Huang Y; Li RA; Yao X
Stem Cells; 2015 Oct; 33(10):2973-84. PubMed ID: 26269433
[TBL] [Abstract][Full Text] [Related]
40. Mechanism for muscarinic inhibition of I(Ca(L)) is determined by the path for elevating cyclic AMP in cardiac myocytes.
Imai Y; Jiang B; Pappano AJ
Cardiovasc Res; 2001 Aug; 51(2):331-43. PubMed ID: 11470473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
